CD36 and neoplasm: Mouse studies suggest that, at least in some cancers, cells with tumor-initiating capacity express CD36 (which is a fatty acid receptor) and that stimulation of CD36-expressing cells with the fatty acid palmitate increased metastasis size and frequency [9].